Forbes July 28, 2021
Amy Feldman

Bill Gates-backed Vicarious Surgical, which is set to go public in a SPAC deal, hopes to reach $1 billion in revenue by 2027 as it takes on the Goliath of surgical robots.

By Amy Feldman with Aayushi Pratap

As a kid, Adam Sachs, cofounder and CEO of Vicarious Surgical, watched the 1966 science-fiction movie Fantastic Voyage and was enamored of the premise of microscopic surgeons who performed surgery inside a scientist’s brain. “Humans are the wrong size to operate on humans,” he says. “We’re not going to shrink humans down, but we can create avatars of them. We can create little miniature robotic versions.”

That’s just what he and his Vicarious Surgical cofounders—Sammy Khalifa, the company’s chief technology officer,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Provider, Robotics/RPA, Technology, Trends
Amazing Technologies Changing The Future Of Dermatology - 2
Humanoids: Transforming Industries And Leading The Future Of Robotics
Surgery's future gold standard
Nvidia advances robot learning and humanoid development with AI and simulation tools
AI Startup Lands $400 Million to Make Robots Handle Objects More Like Humans

Share This Article